Department of Medicine, Alice Springs Hospital, Alice Springs, NT, Australia.
Med J Aust. 2010 May 17;192(10):567-71. doi: 10.5694/j.1326-5377.2010.tb03638.x.
To compare bloodstream infection (BSI) rates, pathogens and mortality among Indigenous and non-Indigenous adults in central Australia.
DESIGN, PARTICIPANTS AND SETTING: Retrospective study of adult patients (aged > or = 15 years) admitted to Alice Springs Hospital (ASH) between 1 January 2001 and 31 December 2005. Patients were followed up until 30 June 2008.
Admission-based and population-based BSI rates and mortality rates for Indigenous and non-Indigenous adults.
During the study period, there were 824 BSI episodes (Indigenous, 753; non-Indigenous, 71). The admission-based BSI rate for Indigenous patients was 26.5 (95% CI, 26.4-26.6) per 1000 adult admissions, compared with 5.2 (95% CI, 5.1-5.2) per 1000 adult admissions for non-Indigenous patients (infection rate ratio [IRR], 5.13 [95% CI, 5.10-5.18]). The population-based BSI rate was 1354.7 (95% CI, 1256.3-1460.8) per 100 000 persons per year among Indigenous patients and 69.9 (95% CI, 55.1-88.6) per 100 000 persons per year among non-Indigenous patients (IRR, 19.4 [95% CI, 15.1-24.9]). These differences were not explained by higher comorbidity levels among Indigenous patients. Human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infected 43% and 35%, respectively, of Indigenous patients tested. The risk of death during the follow-up period was 32.1% for Indigenous and 13.4% for non-Indigenous patients (hazard ratio [HR], 2.69 [95% CI, 1.38-5.25]; P = 0.004). Mortality rates were higher among Indigenous patients who had more than a single BSI (HR, 1.86 [95% CI, 1.32-2.62]; P < 0.001). The mean age at death was 48.5 years (SD, 16.2 years) for Indigenous patients and 75.1 years (SD, 18.7 years) for non-Indigenous patients (P < 0.001).
Indigenous adults living in central Australia experience BSI rates that are among the highest reported in the world. These are associated with a high risk of death, and are a likely consequence of the poor socioeconomic circumstances of Indigenous people.
比较澳大利亚中部地区的土著和非土著成年人血流感染(BSI)的发生率、病原体和死亡率。
设计、参与者和设置:回顾性研究了 2001 年 1 月 1 日至 2005 年 12 月 31 日期间入住爱丽丝泉医院(ASH)的成年患者(年龄≥15 岁)。患者随访至 2008 年 6 月 30 日。
土著和非土著成年人的入院率和人群发病率以及死亡率。
在研究期间,共发生 824 例 BSI (土著,753;非土著,71)。土著患者的入院 BSI 率为每 1000 例成人入院 26.5(95%可信区间,26.4-26.6),而非土著患者为每 1000 例成人入院 5.2(95%可信区间,5.1-5.2)(感染率比[IRR],5.13 [95%可信区间,5.10-5.18])。土著人群的人群发病率为每年每 100000 人 1354.7(95%可信区间,1256.3-1460.8),而非土著人群为每年每 100000 人 69.9(95%可信区间,55.1-88.6)(IRR,19.4 [95%可信区间,15.1-24.9])。这些差异不能用土著患者更高的合并症水平来解释。在接受检测的土著患者中,人类 T 细胞嗜淋巴细胞病毒 1 型和旋毛虫分别感染了 43%和 35%。在随访期间,土著患者的死亡风险为 32.1%,而非土著患者为 13.4%(危险比[HR],2.69 [95%可信区间,1.38-5.25];P = 0.004)。发生多次 BSI 的土著患者死亡率更高(HR,1.86 [95%可信区间,1.32-2.62];P < 0.001)。土著患者的平均死亡年龄为 48.5 岁(标准差,16.2 岁),而非土著患者为 75.1 岁(标准差,18.7 岁)(P < 0.001)。
居住在澳大利亚中部地区的土著成年人经历的 BSI 发生率位居世界最高之列。这些与高死亡风险相关,很可能是土著人民贫困的社会经济状况的后果。